Syndrome des anticorps antiphospholipides : Questions médicales fréquentes
Nom anglais: Antiphospholipid Syndrome
Descriptor UI:D016736
Tree Number:C20.111.197
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes",
"headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes",
"url": "https://questionsmedicales.fr/mesh/D001327",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes",
"code": {
"@type": "MedicalCode",
"code": "D001327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides",
"alternateName": "Antiphospholipid Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Doruk Erkan",
"url": "https://questionsmedicales.fr/author/Doruk%20Erkan",
"affiliation": {
"@type": "Organization",
"name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Hannah Cohen",
"url": "https://questionsmedicales.fr/author/Hannah%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Imad Uthman",
"url": "https://questionsmedicales.fr/author/Imad%20Uthman",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon."
}
},
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium."
}
},
{
"@type": "Person",
"name": "Yu Zuo",
"url": "https://questionsmedicales.fr/author/Yu%20Zuo",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparison of breast fine-needle aspiration cytology and tissue sampling for high-throughput proteomic analysis and cancer biomarker detection.",
"datePublished": "2024-05-30",
"url": "https://questionsmedicales.fr/article/38815563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000539478"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-naïve Men.",
"datePublished": "2024-04-22",
"url": "https://questionsmedicales.fr/article/38694877",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euros.2024.04.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.",
"datePublished": "2024-04-15",
"url": "https://questionsmedicales.fr/article/38619974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/03936155241244802"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing Colorectal Cancer Tumor Bud Detection Using Deep Learning from Routine H&E-Stained Slides.",
"datePublished": "2024-04-03",
"url": "https://questionsmedicales.fr/article/38752165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1117/12.3006796"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images.",
"datePublished": "2024-03-21",
"url": "https://questionsmedicales.fr/article/38512626",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11547-024-01806-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome des anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D016736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des anticorps antiphospholipides",
"description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des anticorps antiphospholipides",
"description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des anticorps antiphospholipides",
"description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des anticorps antiphospholipides",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il des symptômes cliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis."
}
},
{
"@type": "Question",
"name": "Peut-on avoir le syndrome sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la grossesse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements de mode de vie recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles être traitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de thromboses augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications."
}
}
]
}
]
}
Fine-needle aspiration cytology (FNAC) specimens are widely utilized for the diagnosis and molecular testing of various cancers. We performed a comparative proteomic analysis of three different sample...
High-throughput proteomic analysis was conducted on matched FNAC, CNB, and surgical resection tissue samples obtained from breast cancer patients. The protein identification, including currently estab...
Compared to tissue samples, FNAC testing revealed a comparable number of proteins (7,179 in FNAC; 7,196 in CNB; 7,190 in resection samples). Around 85% of proteins were mutually identified in all samp...
FNAC is suitable for high-throughput proteomic analysis, in addition to an emerging source that could be used to identify and quantify novel cancer biomarkers....
This study aimed to determine the difference in prostate volume (PV) derived from transrectal ultrasound (TRUS) and multiparametric magnetic resonance imaging (mpMRI), and to further investigate the r...
Patients who underwent an initial prostate biopsy within 3 mo after mpMRI between January 2016 and December 2021 were analyzed retrospectively. The sensitivity, specificity, positive predictive value ...
The median prostate-specific antigen level of 875 patients was 9.79 (interquartile range [IQR]: 7.09-13.50) ng/ml. The median mpMRI-PV and TRUS-PV were 41.92 (IQR: 29.29-60.73) and 41.04 (IQR: 29.24-5...
TRUS-PV and MRI-PV exhibited a strong linear correlation and reached sufficient agreement. The efficiency of TRUS-PSAD and mpMRI-PSAD for PCa detection was comparable. TRUS could be used for PV estima...
In this work, prostate volume (PV) derived from transrectal ultrasound (TRUS) exhibited a strong linear correlation with the PV derived from multiparametric magnetic resonance imaging (mpMRI). The eff...
This study aimed to assess the diagnostic value of human epididymal protein 4 (HE4), a potential novel biomarker for lung cancer, and its combined detection with five other conventional biomarkers in ...
In this retrospective study, 115 lung cancer patients, 50 patients with benign pulmonary disease, and 50 healthy controls were included. Serum HE4, progastrin-releasing peptide (ProGRP), squamous cell...
All six biomarkers showed significantly elevated levels in the lung cancer group compared to both benign pulmonary disease and control groups (...
HE4 and its combined detection held substantial clinical significance in the diagnosis of lung cancer and its histologic subtyping, especially for lung adenocarcinoma and lung squamous cell carcinoma....
Tumor budding refers to a cluster of one to four tumor cells located at the tumor-invasive front. While tumor budding is a prognostic factor for colorectal cancer, counting and grading tumor budding a...
To compare the diagnostic performance of 40 keV and 70 keV virtual monoenergetic images (VMIs) generated from dual-energy CT in the detection of pancreatic cancer....
This retrospective study included patients who underwent pancreatic protocol dual-energy CT from January 2019 to August 2022. Four radiologists (1-11 years of experience), who were blinded to the fina...
Overall, 137 patients (median age, 71 years; interquartile range, 63-78 years; 77 men) were included. Among them, 62 patients (45%) had pathologically proven pancreatic cancer. The 40 keV VMIs had hig...
The 40 keV VMIs showed better diagnostic performance in diagnosing pancreatic cancer than the 70 keV VMIs, along with higher reader confidence....
Surface-enhanced Raman scattering (SERS) technology have unique advantages of rapid, simple, and highly sensitive in the detection of serum, it can be used for the detection of liver cancer. However, ...
Serum samples were collected from 60 patients with liver cancer (27 patients with stage T1 and T2 liver cancer, 33 patients with stage T3 and T4 liver cancer) and 40 healthy volunteers. Herein, immuno...
The experimental results show that the serum LAPs SERS detection combined with multivariate statistical algorithms can be used for effectively distinguishing liver cancer patients from healthy volunte...
This study investigated the potential ability of the fluorescent probe Ly-CHO to detect formaldehyde (FA) in living cells and tumor-bearing mice. Ly-CHO exhibited great selectivity, excellent sensitiv...
A 62-year-old woman with follicular thyroid cancer who had received total thyroidectomy and multiple rounds of radioactive iodine therapy underwent both 18F-FDG and 18F-FAPI PET/CT. 18F-FAPI PET faile...
Prostate cancer is one of the most common malignancies affecting elderly men worldwide and the fifth leading cause of cancer death in men. Prostate cancer includes many histological variants with the ...
Cerebrospinal fluid (CSF) has revealed the unique genetic characteristics of leptomeningeal metastasis (LM) from non-small cell lung cancer (NSCLC). However, the research in this area is still very li...
Patients with LM from NSCLC (n = 80) were retrospectively analyzed. Circulating tumor DNA (ctDNA) in CSF was tested by next-generation sequencing (NGS), with paired extracranial tissue or plasma sampl...
An overwhelming 93.8% of patients carried druggable mutations in NSCLC LM, with EGFR (78.8%) being the most prevalent. Notably, 4 patients who tested negative for driver genes in extracranial samples ...
CSF-based ctDNA analysis is crucial for detecting and characterizing genetic alterations in NSCLC LM. The distinct genetic profiles in CSF and extracranial tissues emphasize the need for personalized ...